Keros Therapeutics appoints Yung H. Chyung as Chief Medical Officer

Keros Therapeutics, Inc.

Dr. Chyung appointed Chief Medical Officer effective November 1, 2024, succeeding Simon Cooper.
He will receive an annual base salary of $510,000 and a target bonus of 40% of base salary.
Eligible for a stock option to purchase 110,000 shares vesting over four years.
Previously Executive VP and CMO at Tourmaline Bio (2022-2024) and CMO at Scholar Rock (2016-2022).
Company press release issued October 16, 2024, announcing the appointment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.